Orthofix Medical (OFIX) Revenue (2010 - 2026)

Orthofix Medical (OFIX) has reported Revenue for 17 consecutive years, with $210.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 3.85% year-over-year to $210.9 million; the trailing twelve-month figure through Jun 2026 stood at $833.2 million (up 2.99% YoY), and the FY2025 full-year result was $822.3 million, up 2.85% from the prior year.
• Revenue was $210.9 million for Q2 2026 at Orthofix Medical, up from $196.7 million in the prior quarter.
• The five-year high for Revenue was $219.9 million in Q4 2025, with the low at $106.4 million in Q1 2022.
• Historically, Revenue has averaged $179.8 million across 5 years, with a median of $195.1 million in 2024.
• Annual changes were most pronounced in 2022 — Revenue declined 2.74% — and 2023, when it soared 64.64%.
• Tracing OFIX's Revenue over 5 years: stood at $122.2 million in 2022, then jumped by 63.97% to $200.4 million in 2023, then advanced by 7.61% to $215.7 million in 2024, then climbed by 1.97% to $219.9 million in 2025, then declined by 4.08% to $210.9 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $210.9 million in Q2 2026, $196.7 million in Q1 2026, and $219.9 million in Q4 2025.